During the past decade, Charles B. Eberhart Cancer Center at DeKalb Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 26 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charles B. Eberhart Cancer Center at DeKalb Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 29 trials, followed by "Alliance for Clinical Trials in Oncology" with 10 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Eastern Cooperative Oncology Group" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charles B. Eberhart Cancer Center at DeKalb Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 52 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 4 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Charles B. Eberhart Cancer Center at DeKalb Medical Center" are "Breast Cancer" (15 trials), "Lung Cancer" (10 trials), "Lymphoma" (7 trials), "Leukemia" (6 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "Charles B. Eberhart Cancer Center at DeKalb Medical Center" in a lesser frequency.

Most popular intervention types in "Charles B. Eberhart Cancer Center at DeKalb Medical Center" are "Drug" (35 trials), "Other" (20 trials), "Biological" (15 trials), "Radiation" (13 trials) and "Procedure" (7 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (8 trials), "cyclophosphamide" (7 trials), "bevacizumab" (6 trials), "biologic sample preservation procedure" (5 trials) and "prednisone" (5 trials). Other intervention names were less common.

The vast majority of trials in "Charles B. Eberhart Cancer Center at DeKalb Medical Center" are 39 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Charles B. Eberhart Cancer Center at DeKalb Medical Center". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 43 completed trials in Charles B. Eberhart Cancer Center at DeKalb Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Charles B. Eberhart Cancer Center at DeKalb Medical Center, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".